Navigation Links
Micromet Announces Changes in Management Team
Date:12/14/2007

BETHESDA, Md., Dec. 14 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the resignation of Christopher Schnittker as Senior Vice President and Chief Financial Officer. Donald A. Zelm, Executive Director Finance, will assume the responsibilities as principal financial officer of the Company and as its interim chief financial officer. He will oversee the Company's financial operations until a new chief financial officer is hired. The Company has initiated a search for a new CFO.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are in clinical development. MT103 (MEDI-538), the first antibody in Micromet's product pipeline developed utilizing the BiTE(R) antibody technology platform, is being evaluated in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia, and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, a subsidiary of Astra Zeneca plc. The second clinical stage antibody is adecatumumab (MT201), a human monoclonal antibody targeting EpCAM expressing tumors. Adecatumumab is being developed by Micromet in collaboration with Merck Serono in a phase
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/ -- Reportlinker.com announces that a new marke..., Mammography Equipment - A Global Market Per...4330/Mammography-Equipment---A-Global-Market-Persp...er in industrialized as well as developing nations...ammography market. Globally, escalating awareness ...
(Date:11/25/2009)...swire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ...products for minimally disruptive surgical treatme...st a conference call on Monday, November 30, 2009,...all will focus on current issues relative to reimb...de comments from management followed by a short qu...
(Date:11/25/2009)... JOHANNESBURG, November 25 ,iThemba...very announced today,that they have signed a colla...s, services. , Pyxis,s world class comput...l be coupled with iThemba,s service division to pr... projects identified through Pyxis,international ...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 1Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 3Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 4Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 6DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 1DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 2
...loratory study shows clinical improvement in patie...), -- Current treatment options have limited be...ive and incurable blood vessel disease, -- Imat...nt of certain cancers, known to inhibit prote...explore potential of imatinib mesylate in PAH in ...
... of FLEXX Trial Presented at the Osteoarthritis Re..., PARSIPPANY, N.J., Oct. 7 Ferring Pharmaceutica...Trial of Osteoarthritis of the,Knee, showing that ...,non-avian high molecular weight form of intra-art...ra-articular saline (IA-saline) for the relief,of ...
Other Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4
(Date:11/27/2009)...t Health™ announced today that Spectrum Heal...aCad Enterprise orthopedic templating solution and... (PRWEB) November 27, 2009 -- Voy...alth (Grand Rapids, Michigan) has licensed its Tra...nd its TraumaCad Extend workflow solution, to allo...
(Date:11/27/2009)... new interactive anatomy education apps from Modal...ealth sciences learning opportunities for iPhone a...C (Vocus) November 27, 2009 -- Modality, Inc. an...ion of Wolters Kluwer Health, today announced the ...n the App Store. Clemente’s Anatomy, Rohen&r...
(Date:11/26/2009)...ber of Americans living with diabetes will nearly ....1 million in 2034. Over the same period, spending...billion to $336 billion, even with no increase in ...e University of Chicago report in the December iss...h diabetes covered by Medicare will rise from 8.2 ...
(Date:11/26/2009)...n an emotional rollercoaster, study finds , ...t the fear factor meets the jubilant sports fan. ,...ally those who root for the winning team -- enjoy ...ted match and victory was in doubt, producing feel...this Thanksgiving weekend as you,re glued to the T...
(Date:11/26/2009)...rch Triangle Dental (RTDental), a leading dental g...ounced the expansion of its services to include LU...Macmillan. , Durham, N...o announce that Dr. Doug Macmillan, an experienced...onal advanced training seminar. RTDental’s ...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ents through the worst of teething , , THOUSAND O...ng relief for their children, the options have bee...he. But now, retailers who sell baby products have...d-winning JeJe Teether by Baby Vibe LLC ( http://w...
...ving, Inc. (NYSE: SRZ ) today announced that it ... March 2, 2009, at 9 a.m. ET to discuss the financ...008. Mark Ordan, chief executive officer, and Rich...e the U.S.). Callers should reference the "Sunrise...
...e likely to get newer treatments, study finds , ... patients who research their disease on the Intern...atest treatments from their doctors, a new study s...t how that information influences their choice of ...
...e become a common thread in the fabric of American... have had some sort of experience with eating diso...n address these issues on your program and keep yo...al psychologist, Dr. Elizabeth Lombardo can discus...
...cal Insight, Inc. Provides Comprehensive Insights,... 23 Over the next five years, new skin tightening...omodulators will drive double-digit growth in the ...udy, which is the only published report providing ...
...uest Raphael Saadiq , , LOS ANGELES, Feb. 23 Sir...al Elton John AIDS Foundation (EJAF) Academy Award... February 22, 2009 at the Pacific Design Center an...arties and raised nearly $4 million. , , The annu...
Other Medicine News:Health News:Groundbreaking JeJe Teether Vibrates Pain Safely Away 2Health News:Groundbreaking JeJe Teether Vibrates Pain Safely Away 3Health News:Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results 2Health News:Media Influences Cancer Care 2Health News:Media Influences Cancer Care 3Health News:National Eating Disorders Awareness Week, February 22-28, 2009 2Health News:New Procedures to Drive Growth of $5 Billion Global Medical Aesthetic Industry 2Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 2Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 3Health News:17th Annual Elton John AIDS Foundation Party Celebrating the Academy Awards Raises Nearly $4 Million 4
MEDPOR Complete Orbit Complex
MEDPOR Inferior Orbital Rims
MEDPOR Orbital Rim Implant (IMORI)
...ight shafts, cross action. Round handle. Divides n...s attained without grooving. Nuclei of any hardnes...leus sustainer. Phaco of pre-chopped nuclear fragm... during grooving is diminished. Shortened ultra so...
Medicine Products: